{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Vvital Biomed Announces Stellar Advisory Board - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kbf0FJbc96\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vvital-biomed-announces-stellar-advisory-board\/\">Vvital Biomed Announces Stellar Advisory Board<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/vvital-biomed-announces-stellar-advisory-board\/embed\/#?secret=kbf0FJbc96\" width=\"600\" height=\"338\" title=\"&#8220;Vvital Biomed Announces Stellar Advisory Board&#8221; &#8212; Market Newsdesk\" data-secret=\"kbf0FJbc96\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"The advisory board members bolster the Vvital team to develop a game-changing mitral valve repair solution PR Newswire MISGAV, Israel, Nov. 24, 2020 \/PRNewswire\/ &#8212; Vvital Biomed (&#8220;Vvital&#8221;), a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel&#8211; and Singapore-based investment group focused on high-growth medical and agrifood technologies, announced that three world-renowned cardiologists have recently joined the advisory board of Vvital, strengthening the company&#8217;s capabilities to build its solution for mitral and tricuspid valve repair. Dr. Horst Sievert\u00a0is the Director of the CardioVascular Center Frankfurt, Chief of the Department of Internal Medicine, Cardiology and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. He is also a Professor of Internal Medicine\/Cardiology at the &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO02152&amp;sd=2020-11-24"}